Luo, Jingtao <br/><br/>
Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.  [electronic resource] 

 -  Cancer letters  01 2017 
 - 39-49 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2016.09.020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinases--metabolism<br/>Acetyl-CoA Carboxylase--antagonists & inhibitors<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Cetuximab--pharmacology<br/>Drug Resistance, Neoplasm<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Glycolysis--drug effects<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Hypoxia-Inducible Factor 1, alpha Subunit--genetics<br/>Lipolysis--drug effects<br/>Male<br/>Mice, Nude<br/>Middle Aged<br/>Mutation<br/>Phosphorylation<br/>RNA Interference<br/>Signal Transduction--drug effects<br/>Squamous Cell Carcinoma of Head and Neck<br/>Time Factors<br/>Transfection<br/>Xenograft Model Antitumor Assays